Federal Register / Vol. 78, No. 133 / Thursday, July 11, 2013 / Notices 41799 

EARLY TERMINATIONS GRANTED—Continued 

[June 1, 2013 thru June 30, 2013] 

06/20/2013 

20130512 ............... G Delta Airlines, Inc.; Virgin Group Holdings Limited; Delta Airlines, Inc. 

20130889 ............... G Centre Capital Investors V, L.P.; Overhill Farms, Inc.; Centre Capital Investors V, L.P. 

20130896 ............... G Blue Acquisition Group, Inc.; Natural Balance Pet Foods, Inc.; Blue Acquisition Group, Inc. 

06/21/2013 

20130930 ............... G Prem Reddy; Catholic Health Initiatives; Prem Reddy. 

20130939 ............... G TransDigm Group Incorporated; General Electric Company; TransDigm Group Incorporated. 

20130963 ............... G salesforce.com, Inc.; ExactTarget, Inc.; salesforce.com, Inc. 

20130965 ............... G Frederic N. Eshelman; Furiex Pharmaceuticals, Inc.; Frederic N. Eshelman. 

20130966 ............... G Apax VIII–A L.P.; rue21, inc.; Apax VIII–A L.P. 

20130971 ............... G B&G Foods, Inc.; Robert’s American Gourmet Foods, LLC; B&G Foods, Inc. 

06/24/2013 

20130958 ............... G AstraZeneca PLC; Vatera Investment Partners LLC; AstraZeneca PLC. 

20130975 ............... G Roark Capital Partners III LP; SKM Equity Fund III, L.P.; Roark Capital Partners III LP. 

20130978 ............... G ACP Materials LP; Aurora Equity Partners II L.P.; ACP Materials LP. 

06/26/2013 

20130924 ............... G AstraZeneca PLC; Omthera Pharmaceuticals, Inc.; AstraZeneca PLC. 

20130948 ............... G Canadian Imperial Bank of Commerce; Invesco Ltd.; Canadian Imperial Bank of Commerce. 

20130957 ............... G Fairfax Financial Holdings Limited; American Safety Insurance Holdings, Ltd.; Fairfax Financial Holdings 

Limited. 

20130967 ............... G Opko Health, Inc.; Prolor Biotech, Inc.; Opko Health, Inc. 

20130972 ............... G International Business Machines Corporation; SoftLayer Holdings, Inc.; International Business Machines

Corporation. 

20130979 ............... G KapStone Paper and Packaging Corporation; Partners Limited; KapStone Paper and Packaging Corporation. 

06/27/2013 

20130823 ............... G Tyman plc; Melrose Industries PLC; Tyman plc. 

20130964 ............... G Carl Zeiss Stiftung; Xradia, Inc.; Carl Zeiss Stiftung. 

20131011 ............... G Davisville Music Publishing Inc.; Sony Corporation; Davisville Music Publishing Inc. 

06/28/2013 

20130955 ............... G Corvex Master Fund LP; Health Management Associates, Inc.; Corvex Master Fund LP. 

20130984 ............... G Mindray Medical International Ltd.; ZONARE Medical Systems, Inc.; Mindray Medical International Ltd. 

20130991 ............... G Lundin Mining Corporation; Rio Tinto plc; Lundin Mining Corporation. 

FOR FURTHER INFORMATION CONTACT: 

Renee Chapman, Contact Representative 

or Theresa Kingsberry, Legal Assistant, 

Federal Trade Commission, Premerger 

Notification Office, Bureau of 

Competition, Room H–303, Washington, 

DC 20580, (202) 326–3100. 

By Direction of the Commission. 

Donald S. Clark, 

Secretary. 

[FR Doc. 2013–16540 Filed 7–10–13; 8:45 am] 

BILLING CODE 6750–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Meeting of the National Advisory 

Council for Healthcare Research and 

Quality 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Notice of public meeting. 

SUMMARY: In accordance with section 

10(a) of the Federal Advisory Committee 

Act, 5 U.S.C. App. 2, this notice 

announces a meeting of the National 

Advisory Council for Healthcare 

Research and Quality. 

DATES: The meeting will be held on 

Friday, July 26, 2013, from 8:30 a.m. to 

3:30 p.m. 

ADDRESSES: The meeting will be held at 

the Eisenberg Conference Center, 

Agency for Healthcare Research and 

Quality, 540 Gaither Road, Rockville, 

Maryland 20850. 

FOR FURTHER INFORMATION CONTACT: 

Jaime Zimmerman, Designated 

Management Official, at the Agency for 

Healthcare Research and Quality, 540 

Gaither Road, Rockville, Maryland, 

20850, (301) 427–1456. For press-related 

information, please contact Alison Hunt 

at (301) 427–1244. 

If sign language interpretation or other 

reasonable accommodation for a 

disability is needed, please contact the 

Food and Drug Administration (FDA) 

Office of Equal Employment 

Opportunity and Diversity Management 

on (301) 827–4840, no later than Friday, 

July 12, 2013. The agenda, roster, and 

minutes are available from Ms. Bonnie 

Campbell, Committee Management 

Officer, Agency for Healthcare Research 

and Quality, 540 Gaither Road, 

Rockville, Maryland, 20850. Ms. 

Campbell’s phone number is (301) 427– 

1554. 

SUPPLEMENTARY INFORMATION:

I. Purpose 

The National Advisory Council for 

Healthcare Research and Quality is 

authorized by Section 941 of the Public 

Health Service Act, 42 U.S.C. 299c. In 

accordance with its statutory mandate, 

the Council is to advise the Secretary of 

the Department of Health and Human 

Services and the Director, Agency for 

Healthcare Research and Quality 

(AHRQ), on matters related to AHRQ’s 

conduct of its mission including 

providing guidance on (A) Priorities for 

health care research, (B) the field of 

health care research including training 

needs and information dissemination on 

health care quality and (C) the role of 

the Agency in light of private sector 

activity and opportunities for public 

private partnerships. 

The Council is composed of members 

of the public, appointed by the 

Secretary, and Federal ex-officio 

members specified in the authorizing 

legislation. 

II. Agenda 

On Friday, July 26, 2013, there will be 

a subcommittee meeting for the National 

Healthcare Quality and Disparities 

Report scheduled to begin at 7:30 a.m. 


emcdonald on DSK67QTVN1PROD with NOTICES
41800 Federal Register / Vol. 78, No. 133 / Thursday, July 11, 2013 / Notices 

The subcommittee meeting is open the 

public. The Council meeting will 

convene at 8:30 a.m., with the call to 

order by the Council Chair and approval 

of previous Council summary notes. The 

meeting is open to the public. The 

meeting will begin with the AHRQ 

Director presenting an update on 

current research, programs, and 

initiatives. Following the Director’s 

Update, the agenda includes 

presentations on AHRQ’s Centers for 

Education and Research in Therapeutics 

(CERTS), the National Quality Strategy 

and Patient and Family Engagement. 

The final agenda will be available on the 

AHRQ Web site at www.AHRQ.gov no 

later than Friday, July 19, 2013. 

Dated: June 28, 2013. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2013–16574 Filed 7–10–13; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Announcement of Requirements and 

Registration for ‘‘I VetoViolence 

Because . . .’’: Teen Dating Violence 

Prevention Public Service 

Announcement Contest 

Authority: 15 U.S.C. 3719 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

Award Approving Official: Thomas R. 

Frieden, MD, MPH, Director, Centers for 

Disease Control and Prevention, and 

Administrator, Agency for Toxic 

Substances and Disease Registry. 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC) located 

within the Department of Health and 

Human Services (HHS) launches the ‘‘I 

VetoViolence Because . . .’’: Teen 

Dating Violence Prevention Public 

Service Announcement Contest. The 

purpose of the contest is to encourage 

the development of video public service 

announcements (PSA) that increase the 

understanding (1) that teen dating 

violence is a public health problem and 

(2) that prevention efforts can stop it 

before it starts. VetoViolence, under 

HHS/CDC’s National Center for Injury 

Prevention and Control (Injury Center), 

asks violence prevention professionals, 

allied organizations, students, 

VetoViolence Facebook page fans, and 

the general public to develop PSAs 

about teen dating violence and the 

importance of prevention. The intended 

effect of the PSAs is to inspire viewers 

to take steps to stop teen dating violence 

before it starts by promoting healthy 

relationships among friends and loved 

ones and within schools and 

communities. The PSA finalists and 

winners will be showcased in three 

categories on the VetoViolence 

Facebook page, allowing participants to 

reach more people with effective and 

creative messages about preventing teen 

dating violence. 

DATES: Contest begins on July 15, 2013 

and ends on August 15, 2013. Judging 

will take place August 16–30, 2013, and 

winners will be notified on September 

6, 2013, with prizes being awarded 

before September 30, 2013. 

FOR FURTHER INFORMATION CONTACT: 

Alan Williams, Media Specialist, 

Division of Violence Prevention, 

National Center for Injury Prevention 

and Control, Centers for Disease Control 

and Prevention, 4770 Buford Highway 

NE., MS F64, Atlanta, GA 30341, 

Telephone: (770) 488–3893, email: 

wzj4@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Subject of Challenge Competition 

Contestants entering the ‘‘I 

VetoViolence Because . . .’’: Teen 

Dating Violence Prevention Public 

Service Announcement Contest will be 

asked to submit short (60 seconds or 

less), self-made PSAs about teen dating 

violence and the importance of 

prevention efforts. 

Eligibility Rules for Participating in the 

Competition 

The challenge is open to any 

contestant—defined as an individual or 

team of U.S. citizens or permanent 

residents of the United States. 

Contestants may submit more than one 

video to the challenge. 

Contestants will be asked to selfidentify as a student, violence 

prevention professional, or member of 

the general public when selecting an 

entry category (Student View, Violence 

Prevention Professional View, or 

General Public View). A student is 

defined as anyone enrolled in middle 

school, high school, or college and 

under age 25. Contestants must be at 

least 13 years of age to enter. 

To be eligible to win a prize under 

this challenge, an individual or entity— 

(1) Shall have registered to participate 

in the competition under the rules 

published by the Centers for Disease 

Control and Prevention’s National 

Center for Injury Prevention and Control 

at vetoviolence.challenge.gov; 

(2) Shall have complied with all the 

requirements under this section; 

(3) In the case of a private entity, shall 

be incorporated in and maintain a 

primary place of business in the United 

States, and in the case of an individual, 

whether participating singly or in a 

group, shall be a citizen or permanent 

resident of the United States; and 

(4) May not be a Federal entity or 

Federal employee acting within the 

scope of their employment; 

(5) Shall not be an HHS employee 

working on their applications or 

submissions during assigned duty 

hours; 

(6) May not be employees of the HHS/ 

CDC Injury Center, judges of the 

challenge, or any other party involved 

with the design, production, execution, 

or distribution of the challenge or their 

immediate family (spouse, parents or 

step-parents, siblings and step-siblings, 

and children and step-children). 

(7) Federal grantees may not use 

Federal funds to develop COMPETES 

Act (www.nsf.gov/statistics/about/ 

BILLS-111hr5116enr.pdf) challenge 

applications unless consistent with the 

purpose of their grant award. 

(8) Federal contractors may not use 

Federal funds from a contract to develop 

COMPETES Act challenge applications 

or to fund efforts in support of a 

COMPETES Act challenge submission. 

An individual or entity shall not be 

deemed ineligible because the 

individual or entity used Federal 

facilities or consulted with Federal 

employees during a competition if the 

facilities and employees are made 

available to all individuals and entities 

participating in the competition on an 

equitable basis. 

By participating in this challenge, 

contestants agree to assume any and all 

risks and waive claims against the 

Federal Government and its related 

entities, except in the case of willful 

misconduct, for any injury, death, 

damage, or loss of property, revenue, or 

profits, whether direct, indirect, or 

consequential, arising from 

participation in this prize contest, 

whether the injury, death, damage, or 

loss arises through negligence or 

otherwise. By participating in this 

challenge, contestants agree to 

indemnify the Federal Government 

against third party claims for damages 

arising from or related to challenge 

activities. 

Registration Process for Participants: 

Contestants must register for the ‘‘I 

VetoViolence Because . . .’’: Teen 

Dating Violence Prevention Public 

Service Announcement Contest 

Challenge through www.challenge.gov. 

Interested persons should read the 


emcdonald on DSK67QTVN1PROD with NOTICES